A screening tool developed in research led at the University of Strathclyde, UK could increase the number of tests on a solid tumour sample by up to 50 times.
The tool is designed for testing at scale the latest immunotherapies, such as Chimeric Antigen Receptor (CAR) T-cell therapy, which is effective against many haematological cancers but presents challenges when used to treat solid tumours.
A city centre building tailored to the commercialisation of life sciences has reached full capacity. The Biosphere opened its doors just three years ago, and is now home to more than 20 businesses, forming a vibrant and innovative life science cluster on Newcastle Helix.
New Board members will provide expert insight into ADME-Tox, biomarker, assay, cell and gene therapy, and immuno-oncology advances
BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today announced the launch of its new Scientific Advisory Board (SAB) comprised of experts in ADME-Tox, drug development, cell and gene therapy, immuno-oncology, and clinical diagnostics.
• Stevenage Bioscience Catalyst celebrates its 10th anniversary
• Events focus on the cutting-edge science of our occupier companies
• The campus is now at the heart of the biggest cluster for cell and gene therapy in Europe.
STEVENAGE 11th July 2022: Stevenage Bioscience Catalyst (SBC) is celebrating 10 years since it opened its doors to life sciences companies. A series of events was held on 6th July to celebrate the some of the breakthrough science being undertaken on campus including a science symposium, celebration lunch and scientific poster exhibition.
RevoluGen Wins 2022 BioNewsRound Award for Translational Research
First Automated Benchtop Fire Monkey HMW-DNA Extraction Installed at Quadram Institute for Pathogen Sequencing and AMR Monitoring
London, UK – 08 July 2022 – UK genomics company, RevoluGen Ltd. (RevoluGen or the Company), is pleased to announce that it has been selected as the winner of the 2022 BioNewsRound Award, for the development and automation of its Fire Monkey High Molecular Weight (HMW) DNA extraction system and successful transfer to its collaborator, Quadram Institute Biosciences (Quadram).
Are you in need a drug delivery system to bring your candidate molecules inside the cell? Are you tired of long and tedious collaborations? Can you imagine being able to arrive at the clinic with your candidate molecule? DIVERSA helps you with your drug delivery challenges.